ImmunoCellular Therapeutics (United States)

Recent papers from ImmunoCellular Therapeutics (United States)

1. Development of a multi-epitope mRNA vaccine targeting tumor-associated antigens for esophageal squamous cell carcinomanpj Vaccines · 2026
2. Single-cell dissection of persistent tumor antigens in non-responders reveals opportunities for TAA-targeted vaccination after neoadjuvant therapy in esophageal squamous cell carcinomaJournal for ImmunoTherapy of Cancer · 2026
3. T cell-specific non-viral DNA delivery and in vivo CAR-T generation using targeted lipid nanoparticlesJournal for ImmunoTherapy of Cancer · 2025
4. NANOSPRESSO: toward personalized, locally produced nucleic acid nanomedicinesFrontiers in Science · 2025
5. Single-cell transcriptome analysis of stem cells from human exfoliated deciduous teeth investigating functional heterogeneity in immunomodulationScientific Reports · 2024
6. A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with GlioblastomaView · 2019
7. An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell–Based Cancer VaccineCancer Immunology Research · 2019
8. Response Assessment in Neuro-Oncology Clinical TrialsJournal of Clinical Oncology · 2017
9. Improvement of IFNg ELISPOT Performance Following Overnight Resting of Frozen PBMC Samples Confirmed Through Rigorous Statistical AnalysisCells · 2014
10. Xylose phosphorylation functions as a molecular switch to regulate proteoglycan biosynthesisProceedings of the National Academy of Sciences · 2014
11. Identification of Novel Human Leukocyte Antigen-A*0201-Restricted, Cytotoxic T Lymphocyte Epitopes on CD133 for Cancer Stem Cell ImmunotherapyStem Cells Translational Medicine · 2013
12. Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastomaCancer Immunology Immunotherapy · 2012